The mast cell: A versatile effector cell for a challenging world

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 14-22

  Galli, Stephen J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allergy; Anaphylaxis; C kit; Fc RI; IgE antibody; Mast cells; Mast cell deficient mice; Mediators; Stem cell factor

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; STEM CELL FACTOR;

ALLERGIC REACTION; CONFERENCE PAPER; EFFECTOR CELL; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; ANIMAL; HUMAN; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; RECEPTORS, IGE; STEM CELL FACTOR;

EID: 0031132767     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237497     Document Type: Article

References (74)

1. American Heritage Dictionary. 2nd College Edition. Boston. Houghton Mifflin. 1985. p 1344.
2. Maximow A: Ober die Zellformcn des lockeren Bindegewebes. Arch Mikrosk Anat Entwick-lungsmech 1905:67:680.
3. Enerbäck L: Mast cell heterogeneity: The evolution of the concept of a specific mucosal mast cell: in Befus AD. Bienenstock J. Denburg JA (eds): Mast Cell Differentiation and Heterogeneity. New York. Raven Press. 1986. pp 1-26.
4. Bienenstock J, Befus AD, Denburg JA: Mast cell heterogeneity: Basic questions and clinical implications: in Befus AD. Bienenstock J. Denburg JA (eds): Mast Cell Differentiation and Heterogeneity. New York. Raven Press. 1986, pp 391-402.
5. Galli SJ: Biology of disease. New insights into 'the riddle of the mast cells’: Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990:62: 5-33.
6. Miller HR P, Huntley JF, Newlands GFJ, Mac-kellar A, Irvine J, Haig DM, MacDonald A, Lammas AD, Wakclin D, Woodbury RG: Mast cell granule proteases in mouse and rat: A guide to mast cell heterogeneity and activation in the gastrointestinal tract: in Galli SJ. Austen KF (eds): Mast Cell and Basophil Differentiation and Function in Health and Disease. New York. Raven Press. 1989. pp 81-91.
7. Selve H: The Mast Cells. Washington. Butter-worths. 1965.
8. Kitamura Y, Go S, Hatanaka S: Decrease of mast cells in IV/IV' mice and their increase by bone marrow transplantation. Blood 1978:52: 447-452.
9. Kitamura Y: Heterogeneity of mast cells and phenotypic changes between subpopulations. AnnuRev Immunol 1989:7:59- 76.
10. 1 mice: Their value for the analysis of the roles of mast cells in biological responses in vivo. Am J Pathol 1987:127:191-198.
11. Galli SJ, Wershil BK: Mast cell deficiency, supplemental update of model No. 348: in Capen CC. Johnson I K. O'Neill TP (eds): Handbook: Animal Models of Human Disease. Fasc. 20. Washington. Registry of Comparative Pathology. Armed Forces Institute of Pathology, in press.
12. Ginsburg H: The in vitro differentiation and culture of normal mast cells from mouse thymus. Ann NY Acad Sci 1963:103:20-39.
13. Nabel G, Galli SJ, Dvorak AM, Dvorak HF, Cantor H: Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 1981:291:332-334.
14. Nagao K, Yokoro K, Aaronson SA: Continuous lines of basophil mast cells derived from normal mouse bone marrow. Science 1981:212: 333-334.
15. Razin E, C'ordon-Cardo C, Good RA: Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from conca-navalin A-stimulatcd splcnocytcs. Proc Natl Acad Sci USA 1981;28:2559-2561.
16. Schrader J W: The in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and la-antigens. has mast ccll-likc granules, and is regulated by a factor released by activated T cells. J Immunol 1981:131:452-458.
17. Tertian G, Yung YP, Guy-Grand D, Moore MAS: Long term in vitro culture of murine mast cells. I. Description of a growth-factor dependent culture technique. J Immunol 1981:127: 788-794.
18. Ihle JN, Keller J, Oroslan S, Henderson LE, Copeland RD, Filch F, Prystowsky MB, Gold-wasser E, Schrader JW, Palaszynski E, Dv M, Lebe B: Biological properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth-factor activity, mast cell growth-factor activity. P cell-stimulating factor activity and histamine-producing factor activity. J Immunol 1983:131:282-287.'
19. Galli SJ, Dvorak AM, Marcum JA, Ishizaka T, Nabel G, Der Simonian II, Pyne K, Goldin JM. Rosenberg RD, Cantor H, Dvorak HF: Mast cell clones: A model for the analysis of cellular maturation. J Cell Biol 1982;95:435-144.
20. Nakano T, Sonoda T, Hayashi C, Yantatodani A, Kanayama Y, Yamamura T, Asai II, Yonezawa T, Kitamura Y, Galli SJ: Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/YF mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985:162:1025-1043.
21. Kanakura Y, Thompson H, Nakano T, Yamamura T-I, Asai H, Kitamura Y, Metcalfe DD, Galli SJ: Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood 1988:72: 877-885.
22. Hunt JE, Stevens RL: Mouse mast cell protcas-es, in Kitamura Y. Yamamoto S, Galli SJ, Greaves MW (eds): Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York. Raven Press. 1995, pp 149-160.
23. Ido H, Itoh II, Tomita M, Murakumo Y, Ko-bayashi T, Maruyama II, Osada Y, Nawa Y: Cloning of the cDN A encoding a novel rat mast cell proteinase. rMCP-3. and its expression in comparison with other rat mast cell proteinases. Bioehem J 1995:311:675-680.
24. Galli SJ, Zsebo KM, Cieissler EN: The kit ligand. stem cell factor. Adv Immunol 1994:55: 1-96.
25. Galli SJ, Tsai M, Wershil BK, Lain S-Y, Costa IJ: The regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the e-kil receptor, hit Arch Allergy Immunol 1995:107:51 53.
26. Martin FH, Suggs SV, Langley KL, Lu HS, Ting J, Okino KH, Morris CF, MeNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sach-dev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Zsebo KM: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990:63:203-211.
27. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HE, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem Cell Factor (SCF) is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990:63:213-224.
28. Williams DE, Eisenman J, Baird A, Rauch C, van Ness K, March CJ, Park LS, Martin U, Mo-chizuki D, Boswell HS, Burgess G, Lyman SD: Identification of a ligand for the e-kit protoon-cogenc. Cell 1990:63:167-174.
29. Huang F, Nocka K, Beier DR. Chu TY, Buck J, Lahm HW. Wellner D. Leder P. Besmer P: The hematopoietic growth factor KL is encoded at the SI locus and is the ligand of the c-kil receptor. the gene product of the IT locus. Cell 1990: 63:225-233.
30. Witte UN: Steel locus defines new multipotent growth factor. Cell 1990:63:5-6.
31. Rodewald L-R, Dessing M, Dvorak AM, Galli SI: Identification of a committed precursor for the mast cell lineage. Science 1996:271:818-822.
32. Hayashi SI, Kunisada T, Ogawa M, Yantaguehi K, Nishikawa SI: Exon skipping by mutation of an authentic splice site of c-kit gene in H'/fT mouse. Nucleic Acids Res 1991:19:1267-1271.
33. Nocka K, Fan J, Chiu E, Chu TY, Ray P, Trakt-man P, Besmer P: Molecular bases of dominant negative and loss of function mutations at the murine c-Air/white spotting locus: IT. IT. IT and IT EM BO J 1990:9:1805-1813.
34. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996; 183:2681-2686.
35. Witham BA: Nomenclature update: Symbols affecting mutant genes. JAX Notes 1995:461.
36. Wershil BK, Tsai M, Cieissler EN, Zsebo KM, Galli SJ: The rat c-kil ligand, stem cell factor, induces c-kil receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kil receptor can induce expression of cellular function. J Exp Med 1992:175:245-255.
37. Coleman JW, Holliday MR, Kimber I, Zsebo KM, Hialli SJ: Regulation of mouse peritoneal mast cell secretory function by stem cell factor. IL-3 or IL-4.J Immunol 1993:150:556-562.
38. Nakajima K, Hirai K, Yamaguchi M, Takaishi T, Ohta K, Morita Y, Ito K: Stem cell factor has histamine releasing activity in rat connective tissue-type mast cells. Bioehem Biophys Res Commun 1992; 183:1076-1083.
39. Colombo M, Horowitz EM, Botana LM, Mac-Glashan DW Jr., Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kil receptor ligand. rhSC'F. induces mediator release from human cutaneous mast cells and enhances IgF.-dcpendent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992:149:599-608.
40. Bischoff SC, Dahinden CA: c-kil ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 1992; 175:237-244.
41. Galli SJ, Wershil BK, Costa JJ, Tsai M: For better or for worse: Does stem cell factor importantly regulate mast cell function in pulmonary physiology and pathology? Am J Respir Cell Mol Bioll 1994:11:644-645.
42. Tsai M, Gagari E, Lantz CS, Fox LG, Galli SJ: Differential release of mast cell interlcukin-6 via e-kit. Blood, in press.
43. Wershil BK, Mekori YA, Murakami T, Galli SJ: I-Fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast-cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987:139:2605-2614.
44. Wershil BK, Wang Z-S, Gordon JR, Galli SJ: Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast-cell-dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991;87:446-453.
45. Young JD-E, Liu C-C, Butler G, Cohn ZA, Galli SJ: Identification, purification, and characterization of a mast-cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci. USA 1987:84:9175-9179.
46. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-a/cachcctin. Nature 1990:346:274-276.
47. Gordon JR. Hialli SJ: Release ofboth preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachcctin by mouse mast cells stimulated by the FceRI. A mechanism for the sustained action of mast-cell-derived TNF-u during IgE-dependent biological responses. J Exp Med 1991:174:103-107.
48. Plant M, Pierce JH, Watson CJ, Hanley-Hyde J, Nortlan RP, Paul WE: Mast cell lines produce lymphokincs in response to cross-linkage of Fct RI or to calcium ionophores. Nature 1989: 339:64-67.
49. Woenar-Filipowiez A, Heusser CH, Moroni C; Production of the haemopoictic grow th factors GM-C'SF and interleukin-3 by mast cells in response to IgF. receptor-mediated activation. Nature 1989:339:150-152.
50. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Hialli SJ, Dor:' ME: Interleukin 3 dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989:170:245-257.
51. Gordon JR, Burd PR, Galli SJ: Mast cells as a source of multifunctional cytokines. Immunol Today 1990:11:458-464.
52. Gordon JR, Galli SJ: Promotion of mouse fibro-blasl collagen gene expression by mast-cells stimulated via the FceRI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J Exp Med 1994:180:2027-2037.
53. Wershil BK, Furuta GT, Lavigne JA, Roy Choudhury A, Wang Z-S. Hialli SJ: Dexamctha-sone or cyclosporin A suppress mast ccll-leuko-evte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast-ccll-dcpendcnt cutaneous inflammation in the mouse. J Immunol 1995:154:1391-1398.
54. Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershil BK: The regulation of tumor necrosis factor-α production in murine mast cells: Pentoxifylline or dexamethasone inhibit IgE-dependent production of TNI-α by distinct mechanisms. Cell Immunol 1996; 171:140-146.
55. Halli SJ, Wershil BK, Gordon JR, Martin TR: Mast cells: Immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses: in Chadwick D. Evered D. Whelan J (eds): IgE. Mast Cells and the Allergic Response. Ciba Foundation Symposium No. 147. Chichester. Wiley 1989. pp 53 73.
56. Galli SJ: New concepts about the mast cell. N Engl J Med 1993:328:257-265.
57. Halli SJ, Costa JJ: Mast-cell-leukocytc cytokine cascades in allergic inflammation. Allergy 1995:50:851-862.
58. Wershil BK, Murakami T, Galli SJ: Mast-cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells arc required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristaic 13-acetate.1 Immunol 1988:140: 2356-2360.
59. Qureshi R, Jaksehik BA: The role of mast cells in tltioglycollate-induced inflammation. J Immunol 1988:141:2090-2096.
60. Echtcnacher B. Mannel DN. Hultner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996:381:75-77.
61. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-a. Nature 1996:381:77-80.
62. Galli SJ, Wershil BK: The two faces of the mast cell. Nature 1996;381:21-22.
63. Matsuda H, Watanabe N, Kiso Y, Hirota S, Ush-io H, Kantian Y, Azuma M, Koyama H. Kita-mura Y: Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol 1990:144:259-262.
64. Costa JJ, Galli SJ: Mast cells and basophils; in Rich RR, Fleisher TA, Schwartz BD, Shearer WT. Strober W (eds); Clinical Immunology: Principles and Practice, ed 1. St Louis. Mosby. 1996. pp 408-430.
65. Brown SJ, Galli SJ, Gleich GJ, Askenase PW: Ablation of immunity to Amblyomma america-num by anti-basophil serum: Cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 1982;129:790-796.
66. Steeves EB, Allen JR: Basophils in skin reactions of mast-cell-deficient mice infested with Dermacentor variabilis. Int J Parasitol 1990; 20:655-667.
67. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, Galli SJ: Mast cell activation enhances airway responsiveness to mcthacholinc in the mouse. J Clin Invest I993;9I:1176-1182.
68. Conroy MC, Adkinson NF Jr., Lichtenstein LM: Measurements of IgE on human basophils: Relation to scrum IgE and anti-IgE-induced histamine release. J Immunol 1977; 118:1317-1321.
69. Stallman PJ, Aalbersc RC, Bruhl PC, Van Elvcn EH: Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol 1977;54:364-373.
70. Malveaux FJ, Conroy MC, Adkinson NF Jr., Lichtenstein LM: IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest 1978:176-181.
71. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet J-P, Galli SJ: IgE enhances mouse mast cell FceRI expression in vitro and in vivo. Evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med. in press.
72. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet J-P. Galli SJ: IgE enhances mouse basophil FceRI expression in vivo (abstract). J Immunol, in press.
73. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Yano K, Miyajima I, Kinet J-P, Galli SJ: IgE enhances mouse and human mast cell FceRI expression, which in turn enhances IgE-dependent mast cell mediator release (abstract). J Immunol, in press.
74. MacGlashan DW, Bochner BS, Adelman DC, Jardicu PM, Togias A, Lichtenstein LM: Scrum IgE level drives basophil and mast cell IgE receptor display. Int Arch Allergy Immunol 1997; 113:45-48